Search U.S. Product Recalls Database

Showing 11061–11080 of 14370 results

Sort:

Ketorolac Tromethamine Injection (Sagent) – incorrect labeling (2014)

Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.

Class IIModerate

FDAOct 3, 2014Nationwide• Sagent Pharmaceuticals Inc

Locoid Hydrocortisone Cream (Valeant) – Subpotent Drug (2014)

Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point

Class IIILow

FDAOct 2, 2014Nationwide• Valeant Pharmaceuticals International

Stay Informed

Search Product Recalls

Ketorolac Tromethamine Injection (Sagent) – incorrect labeling (2014)

Locoid Hydrocortisone Cream (Valeant) – Subpotent Drug (2014)

Ethambutol Hydrochloride Tablets (West-Ward) – Subpotency (2014)

Candesartan Cilexetil Tablets (Sandoz) – impurity specifications (2014)

Hydrocortisone Butyrate Cream (Valeant) – subpotent drug (2014)

Hydroxyprogesterone Caproate Injection (Avella) – Crystallization (2014)

Hydromorphone Injection (Hospira) – Sterility Concern (2014)

Emtriva Oral Solution (Gilead) – Leaking Container (2014)

Amlodipine Besylate Tablets (Zydus) – Tablet Discoloration (2014)

Truvada Tablets (Gilead) – Foreign Substance (2014)

DOPamine Hydrochloride Injection (Baxter) – Sterility Risk (2014)

Bystolic Tablets (Forest) – Dissolution Failure (2014)

Diclofenac-Misoprostol Tablets (Actavis) – Tablet Defect (2014)

Venlafaxine Extended-Release Tablets (Sun Pharma) – Dissolution Issue (2014)

Resevera Action Dietary Supplement (Formulations) - Manufacturing Issue (2014)

Vision Assure Supplement (Formulations) - Manufacturing Issue (2014)

Benzonatate Capsules (Zydus) – Capsule Mixing (2014)

Gene Strength Supplement (Formulations) - Manufacturing Issue (2014)

Losartan Potassium Tablets (Micro Labs) – Uniformity Failure (2014)

Cephalexin Capsules (Physicians Total Care) – Manufacturing Deviation (2014)